Psychogenic tremor: Long term prognosis in patients with electrophysiologically-confirmed disease
✍ Scribed by Andrew McKeon; J. Eric Ahlskog; James H. Bower; Keith A. Josephs; Joseph Y. Matsumoto
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 105 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We describe the presenting features and long‐term outcomes of patients with electrophysiologically‐confirmed psychogenic tremor. Clinical information for all patients with psychogenic tremor confirmed by our Movement Disorders Neurophysiology Laboratory (2003–2004) was reviewed. A follow‐up questionnaire was administered to all included patients in 2007. Psychogenic tremor was documented in 62 patients; 33 responded to the questionnaire (53%). Median onset‐age was 50 years (range, 15–71); 23 were female (70%). Clinical certainty of psychogenic etiology was: definite, 8 (24%); probable, 16 (49%), and possible, 9 (27%). Characteristic electrodiagnostic features of psychogenic tremor were documented in all. All but two patients were ultimately given a definite diagnosis of psychogenic tremor; recommended psychiatric consultation was only done by 12 (36%). Twenty‐one patients (64%) rated tremor disability as moderate or severe after a median follow‐up of 5.1 years (range, 3.3–19). Improvement occurred spontaneously in 5 (15%), and after a specific intervention in 4 (12%), whereas 3 (9%) had mild but unchanged symptoms. The mean duration of symptoms, prior to diagnosis with psychogenic tremor, was significantly shorter for patients with mild or no tremor at follow‐up (P = 0.037). Physiologically‐confirmed psychogenic tremor carries a poor prognosis, with unremitting or worse tremor persisting 3‐years after diagnosis in most. © 2008 Movement Disorder Society
📜 SIMILAR VOLUMES
## Background: Patients with longstanding quiescent crohn's disease on azathioprine usually maintain an excellent quality of life but are also concerned about long-term safety. this may affect adherence to treatment. the aim of the present study was to assess the adherence to azathioprine in a coho
## Abstract The effect on bladder function of protectomy for colitis or Crohn's disease was studied by means of a questionnaire and by pressure/flow cystometry. Thirty-seven patients who had undergone protectomy for inflammatory bowel disease were compared with 34 control patients who had undergone
Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had
## Background: The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term. Methods: A multic